Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000521528 | SCV000621656 | uncertain significance | not provided | 2017-10-26 | criteria provided, single submitter | clinical testing | The T2185K variant in the FAT4 gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The T2185K variant is not observed in large population cohorts (Lek et al., 2016). The T2185K variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is not conserved. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. We interpret T2185K as a variant of uncertain significance. |
Fulgent Genetics, |
RCV005027618 | SCV005662347 | uncertain significance | Van Maldergem syndrome 2; Hennekam lymphangiectasia-lymphedema syndrome 2 | 2024-04-25 | criteria provided, single submitter | clinical testing |